Ex Parte Sommer et alDownload PDFPatent Trial and Appeal BoardDec 12, 201814259904 (P.T.A.B. Dec. 12, 2018) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 14/259,904 04/23/2014 27581 7590 12/14/2018 Medtronic, Inc. (CVG) 8200 Coral Sea Street NE. MS:MVC22 MINNEAPOLIS, MN 55112 FIRST NAMED INVENTOR John L. Sommer UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. C0004090.USU1 1454 EXAMINER MALAMUD, DEBORAH LESLIE ART UNIT PAPER NUMBER 3792 NOTIFICATION DATE DELIVERY MODE 12/14/2018 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): rs.patents.five@medtronic.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte JOHN L. SOMMER and LINDA L. FRANKE Appeal2017-009349 Application 14/259,904 1 Technology Center 3700 Before MICHAEL J. FITZPATRICK, JAMES A. WORTH, and ELIZABETH A. LA VIER, Administrative Patent Judges. LA VIER, Administrative Patent Judge. DECISION ON APPEAL Pursuant to 35 U.S.C. § 134(a), Appellants seek review of the Examiner's rejections of claims 1---6 and 14--17. We have jurisdiction under 35 U.S.C. § 6(b). For the reasons set forth below, we REVERSE. BACKGROUND The Specification relates to implantable medical electrical leads. Spec. 1 :4--5. Claim 1 is illustrative: 1. A medical electrical lead, comprising: an elongated lead body having an outer circumference and provided with an electrode; 1 Appellants identify the real party in interest as Medtronic, Inc. Appeal Br. 2. Appeal2017-009349 Application 14/259 ,904 a push tube, mounted circumferentially around the lead body, the lead body longitudinally movable with respect thereto; a fixation helix mounted to the push tube, extending along a generally helical axis around the outer circumference of the lead body, the fixation helix comprising a free end spaced from and extending from the lead body; and a retention mechanism employable to prevent longitudinal movement of the lead body relative to the push tube. Appeal Br. 13 (Claims Appendix). REJECTIONS MAINTAINED ON APPEAL 1. Claims 1-3 and 14--17 stand rejected under 35 U.S.C. § 102(a)(l) as anticipated by Zarembo. 2 Ans. 2. 2. Claim 4 stands rejected under 35 U.S.C. § 103 as unpatentable over Zarembo and Falk. 3 Ans. 3. 3. Claims 5 and 6 stand rejected under 35 U.S.C. § 103 as unpatentable over Zarembo and Sommer. 4 Ans. 3. DISCUSSION The Examiner's rejection of claim 1 relies on Figure 11 of Zarembo, and its accompanying text in column 13. See Final Action 4. Figure 11 of Zarembo is reproduced below: 2 Zarembo et al., US 7,920,927 B2, issued Apr. 5, 2011. 3 Falk et al., US 7,860,580 B2, issued Dec. 28, 2010. 4 Sommer et al., US 7,532,939 B2, issued May 12, 2009. 2 Appeal2017-009349 Application 14/259 ,904 Fig. 11 Figure 11 of Zarembo is a sectional view of a lead assembly 1100, with an elongate body 1104 extending from proximal end 1106 to distal end 1108, a conductor 1110, and a push tube 1120. Zarembo 13: 17--48. The last clause of claim 1 recites "a retention mechanism employable to prevent longitudinal movement of the lead body relative to the push tube."5 Although the Examiner's rejection of claim 1 relies generally on Figure 11 of Zarembo, the rejection does not cite to any particular passage or element of Zarembo as teaching the claimed retention mechanism. See Final Action 4. In the Answer, 6 the Examiner identifies a specific corresponding structure in Zarembo (flange 1130 of Figure 11) as capable of preventing longitudinal movement of the lead. Ans. 5. In support, the Examiner quotes Zarembo's written description: "the flange 1130 engages against a surface 5 Claim 5, the only other independent claim on appeal, includes an identical clause. See Appeal Br. 14 (Claims Appendix). 6 As Appellants point out (see Reply Br. 2) the Examiner's reliance on flange 1130 of Zarembo appears to be new in the Answer. Because we are not persuaded by the merits of the Examiner's position, we need not further address its potential procedural aspects. See 37 C.F.R. § 4I.39(a)(2) ("[A]ny rejection that relies upon any Evidence not relied upon in the Office action from which the appeal is taken (as modified by any advisory action) shall be designated by the primary examiner as a new ground of rejection."). 3 Appeal2017-009349 Application 14/259 ,904 1128 during insertion of the active fixation device 1102 and acts as a depth stop to prevent deeper insertion of the active fixation device 1102 into the surface 112 8." J d. ( quoting Zarembo 14: 10-14). We agree with Appellants (see Appeal Br. 6; see also Reply Br. 2) that the Examiner has not established that Zarembo discloses a retention mechanism as claimed. As the above-quoted passage from Zarembo demonstrates, in "act[ing] as a depth stop" (Zarembo 14: 12-13), the flange 1130 would stop further longitudinal movement (in the distal direction) of the entire device. In contrast, the retention mechanism of claim 1 must be capable of "prevent[ing] longitudinal movement of the lead body relative to the push tube." Appeal Br. 13 (Claims Appendix). Because the Examiner has not identified any structure in Zarembo capable of satisfying this claimed intended use, we cannot sustain the rejection of claim 1 on this record. All of the rejections rely similarly on Zarembo. Accordingly, we reverse all of the rejections. CONCLUSION The rejections of claims 1---6 and 14--17 are reversed. REVERSED 4 Copy with citationCopy as parenthetical citation